The past decade has seen a veritable explosion in our knowledge of cardiac membrane conductances, largely due to the ability to obtain healthy isolated cardiac myocytes. Most of this new information has been obtained from ventricular and atrial myocytes because of the ease with which they are dissociated. In contrast much less progress has been made on the Purkinje myocyte although examining its properties is central to understanding the origin of many life threatening arrhythmias. Our laboratory has developed a reliable technique for the dissociation of Purkinje myocytes from their collagenous matrix. We study the electrophysiologic properties of the isolated Purkinje myocytes and also those of the Purkinje fibers. In the present application we propose to continue our studies of three Purkinje membrane currents: the inward rectifier current iK1, the pacemaker to a number of important questions. With respect to iK1 these questions include the origin or rectification, the role played by internal K in gating iK1, and the control of the inactivation of this conductance by B stimulation. Our investigations of the pacemaker current will center on our recent finding that acetylcholine can reverse B agonist effects on if without having direct effects of its own. We will also investigate the origin of the pacemaker activation delay. Our studies of the Na/K pump current will attempt to elucidate the reasons for an order of magnitude difference in the ability of dihydroouabain to inhibit the Na/K pump current in ventricular versus Purkinje myocytes. A second set of experiments examines the interaction of the Na/K pump with the Na/Ca exchanger in response to a calcium load, or in response to prolonged blockade of the Na/K pump by cardiac glycosides. These studies should provide us with important insights into the normal electrophysiology and pharmacology of the Purkinje myocyte, and how this normal function can be modified.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL020558-16
Application #
3485696
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1977-04-01
Project End
1995-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
16
Fiscal Year
1992
Total Cost
Indirect Cost
Name
State University New York Stony Brook
Department
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Potapova, Irina A; Doronin, Sergey V; Kelly, Damon J et al. (2008) Enhanced recovery of mechanical function in the canine heart by seeding an extracellular matrix patch with mesenchymal stem cells committed to a cardiac lineage. Am J Physiol Heart Circ Physiol 295:H2257-63
Rosen, Michael R (2005) 15th annual Gordon K. Moe Lecture. Biological pacemaking: in our lifetime? Heart Rhythm 2:418-28
Valiunas, V; Polosina, Y Y; Miller, H et al. (2005) Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J Physiol 568:459-68
Kochupura, Paul V; Azeloglu, Evren U; Kelly, Damon J et al. (2005) Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112:I144-9
Gao, J; Wang, W; Cohen, I S et al. (2005) Transmural gradients in Na/K pump activity and [Na+]I in canine ventricle. Biophys J 89:1700-9
Qu, Jihong; Kryukova, Yelena; Potapova, Irina A et al. (2004) MiRP1 modulates HCN2 channel expression and gating in cardiac myocytes. J Biol Chem 279:43497-502
Potapova, Irina; Plotnikov, Alexei; Lu, Zhongju et al. (2004) Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ Res 94:952-9
Rosen, Michael R; Brink, Peter R; Cohen, Ira S et al. (2004) Genes, stem cells and biological pacemakers. Cardiovasc Res 64:12-23
Rosen, Michael R; Robinson, Richard B; Brink, Peter et al. (2004) Recreating the biological pacemaker. Anat Rec A Discov Mol Cell Evol Biol 280:1046-52
Doronin, Sergey V; Potapova, Irina A; Lu, Zhongju et al. (2004) Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization. J Biol Chem 279:48231-7

Showing the most recent 10 out of 68 publications